Benefits Science Technologies Names Dr. Yiannis Monovoukas to Board of Directors

FOR IMMEDIATE RELEASE

March 20, 2017

The bio-medical entrepreneur and innovator brings more than two decades of related experience to the company.

BOSTON, Mass., March 20, 2017 – Benefits Science Technologies (BST) CEO Stephen Sofoul announced the addition of Yiannis Monovoukas, Ph.D., MBA to BST’s Board of Directors. Dr. Monovoukas is the former Chairman, President, and CEO, and major shareholder of TEI Biosciences Inc. and TEI Medical Inc., two regenerative medicine companies based on technology generated at MIT focusing on the repair, reinforcement, and regeneration of soft tissues.

“An award-winning entrepreneur and innovator, Dr. Monovoukas brings a wealth of experience in the bio-medical arena to our organization,” said Sofoul. “We expect many great contributions from him.”

Dr. Monovoukas has been the recipient of a number of science and business awards, including the prestigious Ernst & Young Entrepreneur of the Year® award for 2011 New England in the Life Sciences. He also serves on the board of directors of science-based companies in the United States, England, and Europe. He holds a BS degree from Columbia University and MS and Ph.D. degrees from Stanford University, all in chemical engineering, as well as an MBA from the Harvard Business School.

About Benefits Science Technologies

BST provides data analytics software/analysis to employers and consultants to help manage the risk of self-funded health plans. The firm improves connection to data, empowers optimal decisions to control costs, and improves quality of care for plan members.

Founded in 2012, BST is recognized as a world-leading research and applied science team, applying advanced analytics and Robust Optimization to complex health insurance decisions. The MIT-trained team is led by a 30-year MIT professor and Co-Director of the Operations Research Center. BST combines world-class technical knowledge and practical financial experience.

A powerful and unique feature of the platform lies in its ability to provide prescriptive recommendations. BST’s Health Plan Optimizer designs optimal health plan configurations while obeying overall premium, business quality, and other plan owner-specified criteria.

BST enables consultants/brokers and employers to model “what if” scenarios for plan configuration, including stop loss and supplemental plan design. BST delivers timely, customized business intelligence, tailored to the specific healthcare needs of the group. This empowers decision-makers to maximize every healthcare dollar. BST is headquartered in Boston, MA, with offices in Atlanta, GA, and Houston, TX.

Media Contacts

Benefits Science Technologies

Mark Hufham  mhufham@benefitsscience.com